ArticleBMC cancer2026

Prognostic value of PSA Kinetic Ratio in high-volume mCSPC patients treated with abiraterone or enzalutamide: a single-center retrospective study.

Sila Oksuz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.